ClinicalTrials.gov
ClinicalTrials.gov Menu

Safety And Tolerability Of Multiple Dose Lersivirine For 21 Days In Healthy Subjects

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01230385
Recruitment Status : Completed
First Posted : October 29, 2010
Last Update Posted : May 17, 2011
Sponsor:
Collaborator:
ViiV Healthcare
Information provided by:
Pfizer

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : May 2011
  Actual Study Completion Date : May 2011